Loading…
Loading…
Loading…
The oral tablet (Loniten) carries an FDA boxed warning: it may cause pericardial effusion (occasionally progressing to tamponade) and can exacerbate angina, so it is reserved for severe hypertension not manageable with other drugs. Topical minoxidil (Rogaine) has no boxed warning. Low-dose off-label oral minoxidil for hair loss uses far smaller doses, but the tablet's cardiac profile is why it is prescribed and monitored by a clinician.
Incidence rates from clinical trials. Individual experience varies.
| Effect | Incidence | Note |
|---|---|---|
| Scalp irritation, itching, or flaking | Common (topical) | More frequent with the alcohol/propylene-glycol solution than the 5% foam |
| Temporary increased shedding | First 2-8 weeks | A normal "shedding phase" as follicles reset; usually settles by month 2-3 |
| Unwanted facial or body hair (hypertrichosis) | ~15% (low-dose oral) | Dose-related; less common with topical, more with oral |
| Fluid retention / mild ankle swelling | 1.3-10% (oral) | Reported mainly in women on low-dose oral minoxidil |
| Lightheadedness or palpitations | Uncommon (oral) | From the drug's blood-pressure-lowering effect |
Less common but require medical attention.
Was this Minoxidil side-effects guide helpful?